The Conversation (0)
BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, announced the Company closed a private placement with net proceeds of $4,504,524.
BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, announced the Company closed a private placement with net proceeds of $4,504,524.
BioSig Technologies Chariman, Kenneth L. Londoner, stated:
We are pleased to have closed on this growth capital, which will drive our clinical, technology, and commercialization efforts forward. Our shareholder base has now surpassed 650 shareholders of record and the Company continues to deliver on its milestones as we advance toward commercial launch of the PURE EP System.
Connect with BioSig Technologies (OTCQB:BSGM) to receive an Investor Presentation.